{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:41Z","timestamp":1787960201052,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12350-015-0303-4","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T15:54:49Z","timestamp":1447862089000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Rami","family":"Doukky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtihaj","family":"Fughhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Campagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Wassouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-015-0303-4_bib1","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.113.002744","article-title":"Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging","volume":"128","author":"Doukky","year":"2013","journal-title":"Circulation"},{"key":"10.1007\/s12350-015-0303-4_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s12350-013-9676-4","article-title":"The prognostic value of cardiac SPECT performed at the primary care physician\u2019s office","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib3","unstructured":"AMR\/Arlington Medical Resources Inc. Myocardial Study Market Guide, Jan-Jun 2012; 2012."},{"key":"10.1007\/s12350-015-0303-4_bib4","unstructured":"Astellas Pharma US. Lexiscan; 2015."},{"key":"10.1007\/s12350-015-0303-4_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12350-012-9654-2","article-title":"The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.amjcard.2009.08.663","article-title":"Safety of regadenoson in patients with end-stage renal disease","volume":"105","author":"Aljaroudi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s12350-014-0036-9","article-title":"Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials","volume":"22","author":"Rangel","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12350-014-9997-y","article-title":"Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation","volume":"22","author":"Parikh","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ehjci\/jeu036","article-title":"Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction","volume":"15","author":"Bhatti","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-015-0303-4_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jcmg.2012.04.009","article-title":"Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching","volume":"5","author":"Iqbal","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-015-0303-4_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s12350-014-0050-y","article-title":"The prognostic value of regadenoson myocardial perfusion imaging","author":"Hage","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12350-015-0155-y","article-title":"Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging","volume":"22","author":"Farzaneh-Far","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s12350-015-0179-3","article-title":"The prognostic value of regadenoson stress: Has the case been made?","volume":"22","author":"Doukky","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2012.05.008","article-title":"Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"60","author":"Lentine","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12350-012-9533-x","article-title":"Attenuation of the side effect profile of regadenoson: A randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. \u201cThe ASSUAGE trial\u201d","volume":"19","author":"Doukky","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10554-012-0166-6","article-title":"Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease\u2014the ASSUAGE-CKD trial","volume":"29","author":"Doukky","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1007\/s12350-015-0303-4_bib17","article-title":"Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease","author":"AlJaroudi","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12350-009-9062-4","article-title":"ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers","volume":"16","author":"Henzlova","year":"2009","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12350-014-9864-x","article-title":"The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: A substudy of the ASSUAGE trial","volume":"21","author":"Ballany","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12350-015-0087-6","article-title":"The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99 m myocardial perfusion SPECT","volume":"22","author":"Golzar","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12350-013-9765-4","article-title":"The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: A cautionary note in patients with diabetes and coronary artery disease","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.amjcard.2008.07.029","article-title":"Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12350-014-0047-6","article-title":"Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging","volume":"22","author":"Doukky","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s12350-014-9886-4","article-title":"The prognostic value of left ventricular mechanical dyssynchrony using gated myocardial perfusion imaging in patients with end-stage renal disease","volume":"21","author":"Aggarwal","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib25","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s12350-010-9271-x","article-title":"Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease","volume":"17","author":"AlJaroudi","year":"2010","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib26","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.amjcard.2010.05.039","article-title":"Left ventricular mechanical dyssynchrony by phase analysis of gated single photon emission computed tomography in end-stage renal disease","volume":"106","author":"Aljaroudi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1007\/s12350-015-0303-4_bib27","article-title":"Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging","author":"Poulin","year":"2015","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-015-0303-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0303-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123064152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123064152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0303-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-015-0303-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:59:40Z","timestamp":1761026380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123064152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1071358123064152"],"URL":"https:\/\/doi.org\/10.1007\/s12350-015-0303-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-015-0303-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}